501 related articles for article (PubMed ID: 16998859)
1. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury.
Nosseir M; Hinkel A; Pannek J
Neurourol Urodyn; 2007; 26(2):228-33. PubMed ID: 16998859
[TBL] [Abstract][Full Text] [Related]
2. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
Alvares RA; Silva JA; Barboza AL; Monteiro RT
Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
[TBL] [Abstract][Full Text] [Related]
4. Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up.
; Yıldız N; Akkoç Y; Erhan B; Gündüz B; Yılmaz B; Alaca R; Gök H; Köklü K; Ersöz M; Cınar E; Karapolat H; Catalbaş N; Bardak AN; Turna I; Demir Y; Güneş S; Alemdaroğlu E; Tunç H
Spinal Cord; 2014 Jun; 52(6):462-7. PubMed ID: 24732167
[TBL] [Abstract][Full Text] [Related]
5. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
[TBL] [Abstract][Full Text] [Related]
6. Factors that influence the urodynamic results of botulinum toxin in the treatment of neurogenic hyperactivity.
Gutiérrez-Martín P; Vírseda-Chamorro M; Salinas Casado J; Gómez-Rodríguez A; Esteban-Fuertes M
Actas Urol Esp; 2015 May; 39(4):217-21. PubMed ID: 25582926
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
Chen YC; Kuo HC
Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries.
Kuo HC; Liu SH
Neurourol Urodyn; 2011 Nov; 30(8):1541-5. PubMed ID: 21717505
[TBL] [Abstract][Full Text] [Related]
9. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
Ge XT; Li YF; Wang Q; Zhao JN
Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
[TBL] [Abstract][Full Text] [Related]
11. Botulinum injection is useless on fibrotic neuropathic bladders.
Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
[TBL] [Abstract][Full Text] [Related]
12. Long-term urodynamic follow up in pediatric spinal cord injury.
Chao R; Mayo ME
Paraplegia; 1994 Dec; 32(12):806-9. PubMed ID: 7708420
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Botulinum-A toxin injection into bladder to treat neurogenic incontinence in patients with spinal cord injury: comparison of two doses].
Fu G; Wu J; Cong H; Zha L; Li D; Ju Y; Chen G; Xiong Z; Liao L
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3920-3. PubMed ID: 27122214
[TBL] [Abstract][Full Text] [Related]
14. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
15. The neurogenic bladder in spinal cord injury--pattern and management.
Chua HC; Tow A; Tan ES
Ann Acad Med Singap; 1996 Jul; 25(4):553-7. PubMed ID: 8893929
[TBL] [Abstract][Full Text] [Related]
16. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
[TBL] [Abstract][Full Text] [Related]
18. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
Kuo HC
Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
[TBL] [Abstract][Full Text] [Related]
19. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury.
Donnellan SM; Bolton DM
BJU Int; 1999 Aug; 84(3):280-5. PubMed ID: 10468722
[TBL] [Abstract][Full Text] [Related]
20. Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients.
Giannantoni A; Scivoletto G; Di Stasi SM; Silecchia A; Finazzi-Agrò E; Micali I; Castellano V
Spinal Cord; 1998 Jan; 36(1):29-32. PubMed ID: 9471135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]